Treatment Options for Fibromyalgia
For patients with fibromyalgia, a combination of non-pharmacological approaches (particularly exercise) should be initiated first, followed by pharmacological options including amitriptyline, duloxetine, milnacipran, or pregabalin if needed, based on symptom profile and patient characteristics. 1
Non-Pharmacological Management (First-Line)
- Aerobic and strengthening exercise is strongly recommended as the primary non-pharmacological intervention with the highest level of evidence (Ia, A) 1
- Cognitive behavioral therapy is recommended particularly for patients with concurrent mood disorders (Ia, A) 1
- Multicomponent therapies that combine different approaches show benefit (Ia, A) 1
- Specific physical therapies including acupuncture and hydrotherapy/heated pool treatment are beneficial (Ia, A) 1
- Meditative movement therapies (qigong, yoga, tai chi) and mindfulness-based stress reduction can be helpful (Ia, A) 1
Pharmacological Management
First-Line Medications
Amitriptyline at low doses (10-75 mg/day) is recommended for pain reduction and improved function (Ia, A) 1, 2
- Benefits include improved sleep and pain reduction
- Note: Tricyclic antidepressants may be inappropriate for older adults (≥65 years) due to anticholinergic effects 1
Duloxetine or milnacipran (SNRIs) are recommended for pain reduction and functional improvement (Ia, A) 1, 2
Second-Line Medications
Cyclobenzaprine can be considered for pain management (Ia, A) 1
Tramadol is recommended for pain management (Ib, A) when other medications are ineffective 1, 2
- Use with caution due to risk of dependence and side effects
Medications to Avoid
- Corticosteroids are not recommended for fibromyalgia treatment 1, 2
- Strong opioids are not recommended and have not demonstrated benefits for fibromyalgia 1, 3
- NSAIDs have limited evidence for effectiveness in fibromyalgia 3
Treatment Algorithm
Initial approach:
If insufficient response to non-pharmacological approaches:
If inadequate response to first medication:
Important Considerations
- Treatment adherence is often poor - only about 20% of patients continue treatment for ≥1 year 9
- Most patients remain on the same medication dose throughout treatment 9
- Treatment effects for all medications are generally modest, with small to moderate improvements in pain, function, and quality of life 7, 8
- Combination therapy (using multiple medication classes or combining pharmacological with non-pharmacological approaches) may be more effective than monotherapy but requires further research 7, 8